KRT17: Unlocking the Mystery of Cancer Therapy Resistance

19 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Cancer therapy resistance remains a critical challenge in oncology. In this video, we delve into the role of KRT17, a key player in cancer drug resistance across various malignancies. We explore how KRT17 contributes to aggressive tumor behavior, promotes resistance to chemotherapy, and influences the tumor microenvironment. Discover the latest research on KRT17's mechanisms and its potential as a therapeutic target. Learn how targeting KRT17 could revolutionize cancer treatment and improve patient outcomes. Join us as we unravel the complex world of cancer therapy resistance and explore the exciting possibilities of KRT17-targeted strategies.
Categoria
Oncology
Commenta per primo questo video.

Prossimo